Palomar Medical Technologies to Host Fourth Quarter and Year End 2009 Financial Results Conference Call and Webcast on February 11, 2010

BURLINGTON, Mass., Feb. 2 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, will hold its quarterly conference call of its 2009 fourth quarter and year end financial results on Thursday, February 11, 2010 at 11:30AM Eastern Time. If you would like to participate, please call (800) 435-1398 at 11:20 AM Eastern Time on that day. The telephone replay will be available one hour after the call at (888) 286-8010 passcode 13737176 and continue through Thursday, February 18, 2010.

A live webcast of Palomar's conference call will be available in the Investor Relations' section of the Company's web site www.palomarmedical.com. Institutional investors can access the call via Thomson Financial's password-protected event management site, StreetEvents (www.streetevents.com). The online archive will be available one hour after the call and continue through Thursday, February 18, 2010.

For more information on Palomar and its products, visit Palomar's website at www.palomarmedical.com. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the Investor Relations' section of the website.

About Palomar Medical Technologies Inc.: Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In December 2006, Palomar became the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, light-based hair removal device. In June 2009, Palomar became the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, laser device for the treatment of periorbital wrinkles. OTC clearance allows the product to be marketed and sold directly to consumers without a prescription. There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas and salons.  Palomar is testing many new and exciting applications to further advance the hair removal market and other cosmetic applications. Palomar is focused on developing proprietary light-based technology for introduction to the mass markets.

Contacts:

Kerry McAnistan

Investor Relations Assistant

Palomar Medical Technologies, Inc.

781-993-2411

[email protected]

SOURCE Palomar Medical Technologies, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED